Denmark· DK-28105452714

Spasmium Vet.

A butyyliskopolamiini ja analgeetti product containing hyoscinbutylbromid, metamizolnatrium, registered in Denmark by VetViva Richter GmbH. The same ATC class is registered in 2 of our 19 countries.

ATC QA03DB04

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedSpasmium Vet.ATCQA03DB04REGISTER NO.DK-28105452714PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Hyoscinbutylbromid, metamizolnatrium is registered in 2 of 19 countries.

Countries holding a registration under ATC QA03DB04 (butyyliskopolamiini ja analgeetti), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 1 of them publish a price we can compare per daily dose

Hyoscinbutylbromid, metamizolnatrium · ATC QA03DB04

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Hyoscinbutylbromid, Metamizolnatrium
Manufacturer
VetViva Richter GmbH
Country
Denmark (DK)
ATC code
QA03DB04
ATC class
Butyyliskopolamiini ja analgeetti
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28105452714

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1322e59c-a8b0-494a-b8db-31cdb9b2baf4
GET /v1/drugs/1322e59c-a8b0-494a-b8db-31cdb9b2baf4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning",
  "source": "dkma",
  "strength": "500 mg/ml+4 mg/ml",
  "auth_role": "CMS",
  "dk_drugid": "28105452714",
  "substance": "Hyoscinbutylbromid, Metamizolnatrium",
  "auth_procedure": "Decentral procedure",
  "in_medicinpriser": true,
  "registration_date_serial": "42198"
}

See everything about hyoscinbutylbromid, metamizolnatrium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.